Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients

BACKGROUND: To study the feasibility of down stage the borderline resectable pancreatic cancer (BRPC) to resectable disease, we reported our institutional results using an intensity-modulated radiation therapy (IMRT) simultaneous integrated boost (SIB) dose escalation approach to improve R0 resectab...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaolun, Knoble, Jeanna L., Zeng, Ming, Aguila, Fernando N., Patel, Tara, Chambers, Lowell W., Hu, Honglin, Liu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147831/
https://www.ncbi.nlm.nih.gov/pubmed/27935952
http://dx.doi.org/10.1371/journal.pone.0166606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147831/
https://www.ncbi.nlm.nih.gov/pubmed/27935952
http://dx.doi.org/10.1371/journal.pone.0166606

Ejemplares similares